13.50 stock price down
Change
- 0.80 (5.59%)
Volume
2,700
Exchange
NASDAQ
3:48 PM ET on Sep 15, 2014
Delayed at least 20 minutes.
Provided by eSignal.
4.84 stock price down
Change
- 0.11 (2.22%)
Volume
6,675
Exchange
TASE
10:50 AM IT on Sep 16, 2014
Delayed at least 20 minutes.
Provided by eSignal.
View all »Recent Releases

Sep 16, 2014
RedHill Biopharma to Present at the 14th Annual Biotech In Europe Forum for Global Partnering & Investment

Sep 15, 2014
RedHill Biopharma to Present at the 7th Annual BioPharm America International Partnering Conference

Sep 4, 2014
RedHill Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference

View all »Upcoming Events & Presentations

Sep 22, 2014 - Sep 24, 2014
BioPharm America 2014
Boston, MA, USA

Sep 30, 2014 - Oct 1, 2014
14th Annual Biotech In Europe Forum for Global Partnering and Investment
Congress Center Basel, Switzerland

Investor Relations (US):

Lauren Glaser
Vice President
The Trout Group LLC
Direct: +1 646 378 2972
Cell: +1 215 740 8468
email: lglaser@troutgroup.com

Investor Relations (Israel):

Eran Gabay
Vice President & Managing Director
Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
Direct: +972 (0)3 6070 591
email: erang@gk-biz.com

General:

RedHill Biopharma Ltd.
21 Ha’arba’a St., Tel-Aviv 64739, Israel
Tel: +972 (0)3 541 3131
Fax: +972 (0)3 541 3144
email: info@redhillbio.com